Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial crawled date : 2021 - 11 - 30 save search
Gates Industrial to Participate in Credit Suisse's 9th Annual Global Industrials Conference
Published: 2021-11-30 (Crawled : 23:00) - prnewswire.com
GTES | $17.2 0.12% 0.0% 1.3M
|
Producer Manufacturing
|
| O: 0.8%
H: 0.61%
C: -2.51%
trials trial conference
Dycom Industries, Inc. to Participate in the 3rd Annual Truist Securities Industrials and Services Virtual Summit
Published: 2021-11-30 (Crawled : 22:00) - globenewswire.com
DY | $135.56 0.63% 0.0% 170K
|
Industrial Services
|
| O: 1.18%
H: 0.45%
C: -5.9%
trials trial
Longeveron Announces Phase 2 Clinical Trial in Japan to Test Safety and Efficacy of Lomecel-B on Aging Frailty Patients
Published: 2021-11-30 (Crawled : 21:00) - globenewswire.com
LGVN 1 d | $1.93 -3.98% -4.15% 460K
|
|
| O: -8.73%
H: 6.96%
C: -14.84%
phase 2 trial test lomecel-b
Global Industrial Valves and Actuators Market Report 2021: Future Growth Potential Driven by the Shift Toward Sustainable Energy and Technology Enabled New Business Models
Published: 2021-11-30 (Crawled : 20:00) - prnewswire.com
FLS | $45.8 0.37% 0.0% 670K
|
Producer Manufacturing
|
| O: 0.36%
H: 1.24%
C: -3.62%
technology trial energy potential growth
Ensysce Biosciences Announces Clinical Trial Progress of its New Class of Opioids
Published: 2021-11-30 (Crawled : 15:00) - biospace.com/
ENSC | News | $0.561 -3.31% -3.42% 190K
|
Health Technology
|
| O: 2.83%
H: 0.0%
C: 0.0%
trial opioid bioscience
Allakos Announces Expansion of Lirentelimab Development into Atopic Dermatitis, Chronic Spontaneous Urticaria and Asthma
Published: 2021-11-30 (Crawled : 15:00) - biospace.com/
ALLK | $1.065 0.47% 0.47% 420K
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
atopic dermatitis expansion dermatitis urticaria
Kintara Announces First International Site Activation in GCAR Phase 2/3 Clinical Trial for Glioblastoma
Published: 2021-11-30 (Crawled : 15:00) - biospace.com/
KTRA | $0.1204 12.95% 11.46% 7.1M
|
Distribution Services
|
| O: 0.0%
H: 1.04%
C: -2.78%
phase 2 phase 2/3 trial glioblastoma
DESTINY-Breast11 Neoadjuvant Phase 3 Trial of ENHERTU® Initiated in Patients with High-Risk HER2 Positive Early-Stage Breast Cancer
Published: 2021-11-30 (Crawled : 14:30) - biospace.com/
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
risk trial positive cancer phase 3 breast cancer initiated her2- her2
Jazz Pharmaceuticals Announces First Patient Enrolled in IMforte Phase 3 Trial Evaluating Zepzelca® (lurbinectedin) in Combination with a PD-L1 Inhibitor in Small Cell Lung Cancer
Published: 2021-11-30 (Crawled : 14:00) - biospace.com/
JAZZ | $109.96 0.63% 0.63% 760K
|
Health Technology
|
| O: -3.5%
H: 0.0%
C: 0.0%
trial lung cancer cancer phase 3 enroll
Lineage Reports Fourth Case of Retinal Tissue Restoration With OpRegen®
Published: 2021-11-30 (Crawled : 14:00) - biospace.com/
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
retina
CNH Industrial completes the acquisition of Raven Industries
Published: 2021-11-30 (Crawled : 13:30) - globenewswire.com
CNHI | $12.31 -0.73% 0.0% 6.9M
|
Producer Manufacturing
|
| O: -2.07%
H: 0.0%
C: 0.0%
acquisition trial
NiKang Therapeutics and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Novel Combination Therapies for the Treatment of Advanced Clear Cell Renal Cell Carcinoma
Published: 2021-11-30 (Crawled : 13:30) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -4.99%
H: 0.0%
C: 0.0%
treatment renal trial therapeutics collaboration cell carcinoma
Hoth Therapeutics' Enrollment and Dosing in Second Cohort in Phase 1b Human Trial for Atopic Dermatitis Under Way
Published: 2021-11-30 (Crawled : 13:00) - ir.hoththerapeutics.com
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 0.06%
H: 4.32%
C: -1.8%
atopic dermatitis phase 1 dermatitis phase 1b trial therapeutics enroll phase 2b
Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress
Published: 2021-11-30 (Crawled : 13:00) - biospace.com/
CYBN | $0.3677 -0.6% 0.35% 1.8M
|
n/a
|
| O: 3.4%
H: 0.66%
C: -3.29%
new drug fda phase 2 drug trial approval covid
Seres Therapeutics Announces First Patient Enrolled in Phase 1b Study of SER-155, an Investigational Microbiome Therapeutic to Reduce the Risk of Antibiotic-Resistant Bacterial Infections and Graft-Versus-Host Disease (GvHD)
Published: 2021-11-30 (Crawled : 13:00) - biospace.com/
MCRB | $0.5671 -2.93% -3.02% 3.7M
|
Health Technology
|
| O: -10.85%
H: 0.0%
C: 0.0%
disease risk bacterial infections phase 1 phase 1b bacteria iot therapeutics enroll infections phase 2b
ImmunoGen Announces Positive Top-Line Results from Pivotal SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer
Published: 2021-11-30 (Crawled : 12:30) - biospace.com/
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 39.31%
H: 0.0%
C: 0.0%
positive results cancer ovarian cancer trial mirvetuximab topline
First Wave BioPharma Announces Independent Data Monitoring Committee Provides Positive Interim Safety Assessment for Part 2 COVID-19 RESERVOIR Clinical Trial of Niclosamide for the Treatment of Gastrointestinal Infections
Published: 2021-11-30 (Crawled : 12:00) - globenewswire.com
FWBI | $2.59 -8.8% -9.65% 83K
|
Manufacturing
|
| O: 42.63%
H: 0.0%
C: 0.0%
treatment biopharma test positive gastrointestinal trial covid infections
Report of Placebo-Controlled Clinical Trial Evaluating MultiStem® Cell Therapy for Acute Respiratory Distress Syndrome Published in Intensive Care Medicine
Published: 2021-11-30 (Crawled : 12:00) - biospace.com/
ATHX | $0.1018 -40.86% 95M
|
Health Technology
|
| O: 7.62%
H: 0.0%
C: 0.0%
therapy respiratory trial syndros
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.